(Reuters) – Investors are gauging how a potential deterioration in President Donald Trump’s health could impact asset prices in coming weeks, as the U.S. leader remains hospitalized after being diagnosed with COVID-19.
Trump’s diagnosis fuels uncertainty for skittish U.S. stock market
This entry was posted in Syndicated. Bookmark the permalink.

